In a study addressing the genetic characterization of ovarian carcinomas associated with paraneoplastic cerebellar degeneration and anti-Yo antibodies (Yo-PCD), somatic mutations in the Yo antigens CDR2 and CDR2L were found in 65% of the tumors. The gene discussed is CDR2; the disease is cerebellar degeneration.